Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Harvard Business School
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Last Updated: December 2, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211488


Email this page to a colleague

« Back to Dashboard

NDA 211488 describes CAMCEVI KIT, which is a drug marketed by Foresee Pharms and is included in one NDA. There are three patents protecting this drug. Additional details are available on the CAMCEVI KIT profile page.

The generic ingredient in CAMCEVI KIT is leuprolide mesylate. There are twenty-two drug master file entries for this compound. Additional details are available on the leuprolide mesylate profile page.
Summary for 211488
Tradename:CAMCEVI KIT
Applicant:Foresee Pharms
Ingredient:leuprolide mesylate
Patents:3
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 211488
Generic Entry Date for 211488*:
Constraining patent/regulatory exclusivity:
Dosage:
EMULSION;SUBCUTANEOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:EMULSION;SUBCUTANEOUSStrengthEQ 42MG BASE
Approval Date:May 25, 2021TE:RLD:Yes
Regulatory Exclusivity Expiration:May 25, 2024
Regulatory Exclusivity Use:NEW PRODUCT
Patent:⤷  Free Forever TrialPatent Expiration:Jan 16, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Free Forever TrialPatent Expiration:Jan 16, 2027Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
Colorcon
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.